Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions
European Journal of Nuclear Medicine and Molecular Imaging · 2025-12 · 53 (1) · 30-47
DOI: 10.1007/s00259-025-07390-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 11.06.2025. Verfasst von Zhiling Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Yan-chang-zhong Road, Shanghai, 20007…. Hauptthemen laut MEDLINE: Alpha Particles, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, China University Industry-University-Research Institute Innovation Fund.
Abstract (Originalsprache)
Targeted alpha therapy (TAT) has emerged as a promising radiopharmaceutical modality in precision oncology. Compared to beta-emitters, alpha-emitters exhibit superior properties, including higher linear energy transfer, shorter penetration range, enhanced resistance to hypoxic conditions, and convenient radiation protection. Notably, alpha-emitters also demonstrate therapeutic efficacy against a subset of tumors exhibiting resistance to beta-radiotherapy. In 2013, the first α-particle therapeutic agent, ²²³RaCl₂ (Xofigo®), was approved by the FDA for treating bone metastases in advanced castration-resistant prostate cancer, marking a milestone in clinical translation of alpha-emitters. However, the biological mechanisms underlying alpha-particle-mediated therapeutic effects remain incompletely elucidated, which has hindered the optimization of precision treatment strategies. This review systematically analyzes TAT's tripartite antitumor mechanisms-targeted effects, bystander effects and abscopal effects-thereby constructing a "local-regional-systemic" multidimensional antitumor network. This framework not only clarifies the radiobiological principles of α-emitters but also provides innovative perspectives for advancing TAT applications in tumor precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Yan-chang-zhong Road, Shanghai, 200072, China.
- Institute of Nuclear Medicine, Tongji University School of Medicine, No. 301 Yan-chang-zhong Road, Shanghai, 200072, China.
- Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Yan-chang-zhong Road, Shanghai, 200072, China. yufei_021@163.com.
- Institute of Nuclear Medicine, Tongji University School of Medicine, No. 301 Yan-chang-zhong Road, Shanghai, 200072, China. yufei_021@163.com.
ORCID-Profile: Fei Yu
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- China University Industry-University-Research Institute Innovation Fund
Zitieren
APA
Song, Z., Zhang, J., Qin, S., Luan, X., Zhang, H., Yang, M., Jin, Y., Yang, G., & Yu, F. (2025). Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions. European Journal of Nuclear Medicine and Molecular Imaging, 53(1), 30-47. https://doi.org/10.1007/s00259-025-07390-0
Vancouver
Song Z, Zhang J, Qin S, Luan X, Zhang H, Yang M, et al. Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions. European Journal of Nuclear Medicine and Molecular Imaging. 2025;53(1):30-47. doi:10.1007/s00259-025-07390-0
BibTeX
@article{Song2025,
author = {Song, Zhiling and Zhang, Jiajia and Qin, Shanshan and Luan, Xiaohui and Zhang, Han and Yang, Mengdie and Jin, Yao and Yang, Gang and Yu, Fei},
title = {Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {53},
number = {1},
pages = {30--47},
doi = {10.1007/s00259-025-07390-0}
}
EUVIMED